C4 Therapeutics (CCCC) Competitor Comparison
We are evaluating the key criteria listed to compare C4 Therapeutics (CCCC) against its competitors in the Biotechnology industry.
Market Capitalization
154 / 368Gross Profits
231 / 278Total Revenue
164 / 300EBITDA
240 / 337Free Cashflow
251 / 352Quick Ratio
127 / 357Earnings per Share
187 / 359Dividend yield
0 / 6Total Cash
147 / 358Performance 3 years
275 / 368Performance 5 years
225 / 368Performance 10 years
199 / 368Linearity 3 years
281 / 368Linearity 5 years
154 / 368Linearity 10 years
133 / 368Total Rank
298 / 368Dividend Rank
73 / 368Valuation Rank
265 / 368Piotroski Rank
261 / 368Muliplier Rank
300 / 368Quick Ratio - CCCC ranking 127 / 357
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.